Egdane, Filomena A.

HRN: 25-58-93  Sex: Female

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
08/21/2024
CEFTAZIDIME 1GM (VIAL)
08/21/2024
08/28/2024
IV
1g
Q8h
Nonhealing Wound
Waiting Final Action 
08/21/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
08/21/2024
08/28/2024
IV
600 Mg
Q8h
Nonhealing
Waiting Final Action 
09/12/2024
CEFTRIAXONE 1G (VIAL)
09/12/2024
09/19/2024
IV
1g
Q8
DM Foot Left
Waiting Final Action 
09/12/2024
CLINDAMYCIN 150MG/ML, 4ML (AMP)
09/12/2024
09/19/2024
IV
600mg
Q8
DM Foot Left
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: